DoD Ovarian Cancer Clinical Trial Translational Endpoints Research Award

0 保存 · 0 分享 · 1 评论参与讨论

资助机构

Army Medical Research Acquisition Activity (AMRAA)

Department of Defense (DOD)

地区

United States

研究领域

Science and Technology and other Research and Development

截止日期

Aug 06, 2024 12:00:00 AM EDT

基金规模

1600000

联系方式

Abigail Strock Contract Specialist Help@eBRAP.org

申请资格

Eligible Applicants:

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

基金编号

HT942524OCRPCTTERA

说明

The FY24 OCRP Clinical Trial Translational Endpoints Research Award intends to support correlation of clinical trial-related data (e.g., biosample analysis, imaging, or epidemiological data) with clinical outcomes or responses to therapies. Correlative studies may be associated with a past, ongoing, or future clinical trial in order to associate various factors (genetic, DOD FY24 Ovarian Cancer Clinical Trial Translational Endpoints Research Award 4

biochemical, environmental and others) with initiation, progression, metastasis, recurrence, prognosis, diagnosis or effect of intervention on ovarian cancer outcomes. The translational research should address high-impact or unmet needs in ovarian cancer. The proposed research may be hypothesis testing or may be designed to generate new hypotheses to be tested in follow-up clinical research. The award may not be used to directly support a clinical trial.

基金资源
Purdue Grant Writing Lab: Introduction to Grant Writing	打开链接
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal	打开链接